MSc. Alina Melisa Manea

Precision Oncology Scientist (MSc)
Molecular Biologist & Geneticist

Her work focuses on clinical data curation, the definition of personalized treatment strategies, and genomic data analysis for Molecular Tumor Boards (MTBs). Within this scope she clinically interprets comprehensive genomic profiles and scientifically curates, interprets, and reports molecular biomarker data in the oncology context. By ensuring coordination among scientists, clinicians, and diagnostic teams, she aims to reveal the clinical relevance of multi-omic data, optimize targeted treatment options, and identify resistance mechanisms.

She aims to integrate precision oncology standards into clinical practice. To this end she maintains collaborations with leading genomic profiling companies, international consortia, and respected academic institutions. These multi-partner translational research efforts and scientific publications serve as a bridge for delivering the most current treatments to patients.